Sentence examples for scarce trial from inspiring English sources

A scarce trial in which carboplatin was tested at a 3-weekly period, as foreseen in our study, but at a dosage of only 400 mg m−2 in metastatic breast cancer patients, yielded leucopenia grade 3 4 in two out of 20 (10%) patients and thrombocytopenia grade 3 in one out of 20 (5%) patients as worst haematological toxicities.

Data on adverse bleeding from the randomised controlled trials are scarce: one trial reported two cases of fatal bleeding in the intervention arm (2/97 given vitamin E v 0/99 given placebo), 27 and one reported non-fatal bleedings (16/2231 given vitamin E v 14/2264 given placebo).

The data to support such recommendations are scarce, and large trials are needed to clarify this issue.

Saito et al reported that 50% of patients in general and 70% of all participants in clinical trials stated that the amount of information regarding clinical trials is scarce, and people perceive that the information services related to clinical trials to be insufficient in Japan [ 16].

Although human data are still scarce, a double-blind trial involving more than 1000 breast cancer cases after surgery indicates that a 2-year treatment with clodronate can reduce the incidence of bone metastases by about one-half, and prolong patient survival (Powles et al, 2002).

While the clinical trials with TT are scarce, and randomized placebo controlled clinical trials should be done in future.

Particularly, fungal chitin-linked asthma is increasing, but treatment options and successful clinical trials are scarce, necessitating further therapeutic developments.

There is increasing interest for the use of protein supplements, but evidence from well-designed randomized controlled trials is scarce.

Even if randomized controlled trials are scarce, some preliminary results are encouraging and peripheral and central neuromodulating techniques are considered as promising alternatives to pharmacological treatment.

At present, conclusive evidence based on well designed, randomized, and controlled trials remains scarce, limiting implementation of these techniques in daily practice outside a study context.

The carbapenems are widely regarded as the drugs of choice for the treatment of severe infections caused by ESBL-producing Enterobacteriaceae, although comparative clinical trials are scarce.